The addition of Monjuvi to standard-of-care therapy reduced the risk of disease progression, relapse, or death in patients ...

In vivo perturbations and single-cell RNA-seq reveal cell-type-specific STAT1-IFNg signaling in regulation of trained immunity in tissue-resident immune cells.

Ongoing commercial launch of AUCATZYL® on track, with 24 treatment centers fully authorized as of January 10th- National Comprehensive Cancer ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

A complete blood count was performed for all treated patients, with assessment of total lymphocyte count and the subpopulations, including CD5, CD19 and CD20, assessed as frequency and absolute ...

The list includes several groundbreaking therapies that are expected to change the treatment landscape for several diseases and conditions.

Objectives: To evaluate feasibility and safety of CD19 directed CAR T cell therapy in three patients with systemic sclerosis (SSc) not qualifying for autologous stem cell transplantation (HSCT) ...

Although usually identified early, skin lymphomas can be mistaken for other skin conditions, delaying diagnosis. Non-Hodgkin's lymphoma (NHL) occurs when lymphocytes called T cells and B cells become ...